EFFECT OF MUSALI CHURNA IN SENSORY NEURAL HEARING LOSS - A RANDOMIZED CONTROLLED CLINICAL TRIAL

EFFECT OF MUSALI CHURNA (CURCULIGO ORCHIODES) IN BADHIRYA W.S.R TO SENSORY NEURAL HEARING LOSS- A RANDOMIZED CONTROLLED CLINICAL TRIAL

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/07/014722

Enrollment

Registered

2018-07-03

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Hearing loss

Interventions

Intervention1: Musali Churna (Curculigo orchiodes): Musali Churna (Curculigo orchiodes) Dose-6gm two times/day Route of admistration-oral Duration-45 days Control Intervention1: Sarivadi vati : D

Eligibility

Inclusion criteria

Inclusion criteria: Clinical features of Bhadirya. Mild to moderate hearing loss 26 to 40 db and 41 to 55 db Age group 18 to 60 years Irrespective of sex occupation Controlled diabetic patient

Exclusion criteria

Exclusion criteria: Infective diseases like Encephalitis Herpes Mumps Systemic disorders like uncontrolled DM HTN Known case of aural tumours polyps etc CSOM TM perforation

Design outcomes

Primary

Measure	Time frame
Musali Churna (Curculigo orchiodes) may prove as the promising economical treatment for sensory neural hearing loss Timepoint: 18 MONTHS	—

Secondary

Measure	Time frame
Musali Churna (Curculigo orchiodes) may prove as the promising economical treatment for sensory neural hearing loss Timepoint: 45 days	—

Countries

India

Contacts

Public ContactDr Neha

KAHERs Shri B M K Ayurveda Mahavidhalaya

savita.angadi@yahoo.com7411213286

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026